Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Free Cash Flow
Yield10 Bioscience Inc
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Free Cash Flow
$-11.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
8%
|
|
Abbvie Inc
NYSE:ABBV
|
Free Cash Flow
$22.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Free Cash Flow
$3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Free Cash Flow
$3.7B
|
CAGR 3-Years
22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
24%
|
See Also
What is Yield10 Bioscience Inc's Free Cash Flow?
Free Cash Flow
-11.5m
USD
Based on the financial report for Sep 30, 2023, Yield10 Bioscience Inc's Free Cash Flow amounts to -11.5m USD.
What is Yield10 Bioscience Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
8%
Over the last year, the Free Cash Flow growth was -4%. The average annual Free Cash Flow growth rates for Yield10 Bioscience Inc have been -6% over the past three years , -6% over the past five years , and 8% over the past ten years .